Pharmaceuticals

A new rule will soon require most drug ads on TV to state the drug's list price. Here's what the science says about how people will likely react.

It's not just drug manufacturers who are feeling the effects of major opioid lawsuits.

The charges mean that two former Rochester Drug Company leaders could face prison time.

Getting off my antidepressant was hell. I'm not alone—and the pharmaceutical industry isn't helping.

A new study suggests drug-company practices helped create the current epidemic.

The House Oversight and Reform Committee announced on Monday the launch of an investigation into the pharmaceutical industry's pricing practices.

The government has never fined anyone for breaking a law about reporting clinical trials. A new effort is trying to change that.

Neglected tropical diseases continue to inflict pain and suffering on large portions of the world's population despite the availability of inexpensive cures in the West.

Before he was named Trump's health secretary, Price took a congressional trip to Australia and pressed officials to extend protections for drug companies in an international trade agreement.

But the people won't, as the push for pharma reform mounts.

OxyContin, designed for cancer pain relief, became the drug prescribed for back and tooth aches.

A study confirms that people who make less than $50,000 a year are 37 percent less likely to participate in clinical trials for new cancer treatments—and that's bad news for everybody involved.

Politicians have plenty of ideas to rein in the ever-growing cost of prescription drugs, but for now, the law still favors biotech companies.

Flow restrictors can help prevent children from taking too much acetaminophen, the active ingredient in Tylenol, which can cause liver damage if taken in high doses.

Hint: It's not because of science.

Even our most personal health conditions are part of a vast but hidden market for our medical data. Don't we deserve to know about it?

An early look at a Pacific Standard story that's currently only available to subscribers.

Why are prescription drugs, like ipilimumab, so expensive?

How the American opiate epidemic was started by one pharmaceutical company.

New research finds people suffering from Parkinson’s responded more strongly to a placebo if it was described to them as an expensive drug.

The biggest pharmaceutical companies are celebrating huge profits while their patients struggle to afford their cancer-fighting drugs.

In the war against malaria, one small corner of the globe has repeatedly turned the tide, rendering our best weapons moot and medicine on the brink of defeat.

Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: "What is scientific and sexy is driven by what can be monetized."

Nearly every large drug maker based in the United States had at least one academic medical center official on its board, raising questions about their independence.